Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating activities    
Net loss $ (35,038) $ (47,785)
Adjustments to reconcile net loss used in operating activities:    
Depreciation and amortization 97 907
Stock-based compensation 5,980 4,522
Accretion of debt discount 686 104
Amount fully reserved 1,000 0
Deferred taxes 15 31
Changes in assets and liabilities:    
Accounts receivable, net 516 (1,943)
Other receivables 2,433 1,210
Inventory, net 15 (17)
Prepaid expenses and other assets 487 910
Accounts payable (1,205) (324)
Accrued expenses and other liabilities (3,537) 4,916
Lease liability, net 14 (34)
Net cash used in operating activities (28,537) (37,503)
Investing activities    
Purchase of property and equipment (56) (21)
Net cash used in investing activities (56) (21)
Financing activities    
Proceeds from issuance of common stock and pre-funded warrants in underwritten public offering, net 0 37,653
Proceeds from Notes and warrants, net of debt issuance costs paid 0 19,615
Prepayment on Notes (14,806) 0
Proceeds from exercise of stock options 0 1,568
Proceeds from issuance of common stock under employee stock purchase plan 25 207
Net cash (used in) provided by financing activities (14,781) 59,043
(Decrease) increase in cash, cash equivalents and restricted cash (43,374) 21,519
Cash, cash equivalents, and restricted cash at beginning of period 54,864 19,106
Cash, cash equivalents, and restricted cash at end of period 11,490 40,625
Supplemental disclosures of cash flow information    
Cash paid for interest 1,657 0
Unpaid debt issuance costs 0 1,715
Cash and cash equivalents 11,249 40,435
Restricted cash, current 14 41
Restricted cash, non-current 227 149
Total cash, cash equivalents and restricted cash $ 11,490 $ 40,625